Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2013
06/19/2013CN1950343B Basic amine compound and use thereof
06/19/2013CN103168039A Imidazopyridines syk inhibitors
06/19/2013CN103168033A Quinazoline compounds as sodium channel blockers
06/19/2013CN103168022A Process for preparing a propiolic acid or a derivative thereof
06/19/2013CN103159788A Condensed imidazole formamide serving as transient receptor potential vanillin 3 (TRPV3) modifier
06/19/2013CN103159768A Indoloquinacridone derivative and application thereof in electroluminescent device
06/19/2013CN103159767A Method for extracting bap-iifoline from sophora flavescens
06/19/2013CN103159766A Synthesis method of novel pharmaceutical intermediate
06/19/2013CN103159765A Indisetron purification method suitable for industrialization
06/19/2013CN103159764A Photo-electricity function material-perylene bisimide type derivative and preparation method thereof
06/19/2013CN103159763A Novel perylene bisimide type photoelectric function material and synthetic method thereof
06/19/2013CN103159762A Epindolidione derivative and application thereof
06/19/2013CN103159761A Simple preparation method of 3-aryl indolizine derivative
06/19/2013CN103159760A Azaindole derivatives as cftr modulators
06/19/2013CN103159759A Preparation method of moxifloxacin hydrochloride
06/19/2013CN103159758A (1S,3S)-1-p-nitrophenyl-1,2,3,4-tetrahydro-beta-carboline acyl amino acid, and synthesis, antithrombotic activity and application as antithrombotic agent thereof
06/19/2013CN103159757A Synthesis method for 2,7-naphthyridine-1(2H)-ketone
06/19/2013CN103159735A Substitutional imidazole kinase inhibitor
06/19/2013CN103159691A Preparing method and application of isothiocyanate compound
06/19/2013CN102241675B (1R,3S)-1-(4-hydroxyl-3-methoxycarboxyl)-1,2,3,4-tetrahydro-beta-carboline-3-formyl amino acid derivatives as well as preparation method and application thereof
06/19/2013CN102093355B C-3 acylated indolizine compound and preparation method thereof
06/19/2013CN102093354B Indolizine Mannich base compound and preparation method thereof
06/19/2013CN101973829B Trifluoromethylation of trifluoromethyl aryl sulfonium salt to heterocyclic compound under metal trigger
06/19/2013CN101880276B Substituted diazepan compounds as orexin receptor antagonists
06/19/2013CN101790531B Process for the preparation of pyrido [2, 1-alpha] isoquinoline derivatives and polymorphic froms thereof
06/19/2013CN101687870B Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
06/19/2013CN101550136B Diarylurea derivatives and application thereof used for preparing anti-neoplastic medicament
06/19/2013CN101437819B Pyridopyrazines and derivatives thereof as alk and c-MET inhibitors
06/19/2013CN101065359B Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery
06/18/2013US8466289 Heterocyclic sulfonamide derivatives
06/18/2013US8466288 Isoindolinone inhibitors of phosphatidylinositol 3-kinase
06/18/2013US8466286 SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors
06/18/2013US8466170 7-azaindole derivatives
06/18/2013US8466169 SF5 derivatives as PAR1 inhibitors, production thereof, and use as medicaments
06/18/2013US8466168 Tricyclic alkylaminomethyloxazolidinone derivatives
06/18/2013US8466167 Compounds and compositions as TLR activity modulators
06/18/2013US8466152 (aza)indole derivative and use thereof for medical purposes
06/18/2013CA2615700C 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
06/18/2013CA2608496C Imidazoquinolines as lipid kinase inhibitors
06/18/2013CA2566898C Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
06/18/2013CA2560896C Imidazole compounds
06/18/2013CA2532800C Anaplastic lymphoma kinase modulators and methods of use
06/13/2013WO2013086229A1 Bicyclic aryl and heteroaryl sodium channel inhibitors
06/13/2013WO2013083666A1 Inhibitors of bruton's tyrosine kinase
06/13/2013WO2013083606A1 Kinase inhibitors
06/13/2013WO2013083604A1 Kinase inhibitors
06/13/2013WO2013083591A1 Substituted pyrazoles as mglu5 receptor modulators
06/13/2013WO2013083206A1 Derivatives of 4-hydroxy-1,2,3,4-tetrahydronaphtalen-1-yl urea and their use in the treatment of, inter alia, diseases of the respiratory tract
06/13/2013WO2013083070A1 1, 4-dihydro-naphthyridine derivative and pharmaceutical composition and use thereof
06/13/2013WO2013046225A3 Process for the preparation of paliperidone palmitate
06/13/2013WO2013043232A3 8-ethyl-6-(aryl)pyrido [2,3-d]pyrimidin-7(8h) -ones for the treatment of nervous system disorders and cancer
06/13/2013WO2012177893A3 Trpm8 antagonists and their use in treatments
06/13/2013WO2012031196A9 4- { [ ( pyridin- 3 - yl -methyl) aminocarbonyl] amino} benzene - sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer
06/13/2013US20130150584 5-anilinoimidazopyridines and methods of use
06/13/2013US20130150578 Novel hypoglycemic compounds
06/13/2013US20130150404 Biphenyl derivatives
06/13/2013US20130150400 Salts, prodrugs and polymorphs of fab i inhibitors
06/13/2013US20130150398 Indole Derivatives as CRTH2 Receptor Antagonists
06/13/2013US20130150392 Iminopropene compound and use thereof
06/13/2013US20130150361 Kinase inhibitors
06/13/2013US20130150360 Inhibitors of bruton's tyrosine kinase
06/13/2013US20130150359 Pyrazoloquinolines
06/13/2013US20130150356 Acyl Piperazine Derivatives as TTX-S Blockers
06/13/2013US20130150353 Fused Tricyclic Inhibitors of Mammalian Target of Rapamycin
06/13/2013US20130150343 Kinase inhibitors
06/13/2013US20130150342 Pyrrolopyrimidine compounds as inhibitors of cdk4/6
06/13/2013US20130150341 Novel compounds
06/13/2013US20130150340 6-(4-Hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
06/13/2013US20130150339 Bicyclic Aryl and Heteroaryl Sodium Channel Inhibitors
06/13/2013US20130150310 Compositions and Methods for Treatment of Cancer
06/13/2013US20130150254 Reagents and methods for direct labeling of nucleotides
06/13/2013CA2858447A1 Kinase inhibitors
06/13/2013CA2858420A1 Derivatives of 4-hydroxy-1,2,3,4-tetrahydronaphtalen-1-yl urea and their use in the treatment of, inter alia, diseases of the respiratory tract
06/13/2013CA2854603A1 Inhibitors of bruton's tyrosine kinase
06/12/2013EP2602255A1 Fused heterocyclic ring compound
06/12/2013EP2601192A1 Fused heterocyclic compounds
06/12/2013EP2601185A1 Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents
06/12/2013EP2601174A1 Substituted indole and azaindole oxoacetyl piperazinamide derivatives
06/12/2013EP2600874A1 Pyrimidine compounds that inhibit anaplastic lymphoma kinase
06/12/2013EP2600872A1 Fused-imidazoyl compounds useful as antimicrobial agents
06/12/2013CN103153997A Quinazoline derivatives
06/12/2013CN103153996A Quinoline and quinoxaline derivatives as kinase inhibitors
06/12/2013CN103153995A Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors
06/12/2013CN103153994A Bicyclic heteroaryl kinase inhibitors and methods of use
06/12/2013CN103153993A Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
06/12/2013CN103153980A Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents
06/12/2013CN103153963A Cyclopropane compound
06/12/2013CN103153958A Novel microbiocidal dioxime ether derivatives
06/12/2013CN103153956A Novel processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide
06/12/2013CN103146375A Benzanthracene organic light-emitting material and preparation method thereof
06/12/2013CN103145711A Azaadamantane ester and carbamate derivatives and methods of use thereof
06/12/2013CN103145710A Synthesis method of indole-imidazole compound
06/12/2013CN103145709A Synthesis process for 4-chloro-1,6-naphthyridine
06/12/2013CN103145708A Method for preparing surface indole diketone and derivative thereof
06/12/2013CN103145707A Preparation method of hydrogenated pyridine [4, 3-b] indole compound
06/12/2013CN103145706A Imidazopyridine compound with anti-inflammatory action and application thereof to preparation of anti-inflammatory medicament
06/12/2013CN103145705A Beta-carboline alkaloid derivatives and their preparation method and medical use
06/12/2013CN103145704A 1,4-dihydro-1,8-nalidixic acid derivatives, their pharmaceutical composition and use of the pharmaceutical composition
06/12/2013CN102584820B Preparation method for 5-bromo-7-azaindole
06/12/2013CN102276606B Tosylate crystalline salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl] -8-phenyl-1,7-diaza-spiro[4.5] decan-2-one and preparation process therefor
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 646